Discrete event simulation: The preferred technique for health economic evaluations?

Value in Health

Volumn 13, Issue 8, 2010, Pages 1056-1060

  Caro, Jaime J ^a,b   Möller, Jörgen ^b   Getsios, Denis ^c  

^a MCGILL UNIVERSITY   (Canada)

^b UNITED BIOSOURCE CORPORATION   (United States)

^c UnitedBioSource Corporation   (Canada)

Author keywords

decision tree; discrete event simulation; economic evaluation; Markov; modeling

Indexed keywords

ARTICLE; COHORT ANALYSIS; HEALTH CARE; HEALTH ECONOMICS; MEDICAL DECISION MAKING; PRIORITY JOURNAL; SIMULATION;

EID: 78650084464     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2010.00775.x     Document Type: Article

References (14)

1. Sculpher MJ, Claxton K, Drummond M, et al. Whither trial-based economic evaluation for health care decision making? Health Econ 2006; 15: 677-87.
2. Lang DL, Lopert R, Hill SR,. Use of pharmacoeconomics in prescribing research. Part 5: modelling-beyond clinical trials. J Clin Pharm Ther 2003; 28: 433-9.
3. Buxton MJ, Drummond MF, Van Hout BA, et al. Modelling in economic evaluation: an unavoidable fact of life. Health Econ 1997; 6: 217-27.
4. Siebert U,. When should decision-analytic modeling be used in the economic evaluation of health care? Eur J Health Econ 2003; 4: 143-50.
5. Eddy DM,. Accuracy versus transparency in pharmacoeconomic modelling. Finding the right balance. Pharmacoeconomics 2006; 24: 837-44.
6. Brennan A, Chick SE, Davies R,. A taxonomy of model structures for economic evaluation of health technologies. Health Econ 2006; 15: 1295-310.
7. Stahl JE,. Modelling methods for pharmacoeconomics and health technology assessment: an overview and guide. Pharmacoeconomics 2008; 26: 131-48.
8. Caro JJ,. Pharmacoeconomic analyses using discrete event simulation. Pharmacoeconomics 2005; 23: 323-32.
9. Miettinen OS, Caro JJ,. Principles of nonexperimental assessment of excess risk, with special reference to adverse drug reactions. J Clin Epidemiol 1989; 42: 325-31.
10. Karnon J, Brown J,. Selecting a decision model for economic evaluation: a case study and review. Health Care Manag Sci 1998; 1: 133-40.
11. L'Ecuyer P,. Efficiency improvement and variance reduction. Winter Simulation Conference Proceedings 1994; 122-32.
12. Caro JJ, Getsios D, Moller J,. Regarding probabilistic analysis and computationaly expensive models: necessary and required? Value Health 2007; 10: 317-8.
13. Van Gestel A, Severens JL, Carroll AB, et al. Modeling complex treatment strategies: construction and validation of a discrete event simulation model for glaucoma. Value Health 2010; 13: 358-67.
14. Banks J, Carson JS, Nelson BL, et al. Discrete Event System Simulation (3rd ed.). Upper Saddle River, NJ: Pearson Education International Series, 2001.